Table 1 Descriptive characteristics CF patients by screening status
Investigated trait | Statistical parameters | |
|---|---|---|
Screened Group CF NBS (n = 27) | Unscreened Group CF (n = 52) | |
Sex, n (%) | ||
Females | 16 (59.26) | 24 (46.15) |
Males | 11 (40.74) | 28 (53.85) |
Birth weight (g), | ||
mean (SD), min.-max. | 3168.52 (715.10), 970–4220 | 3195.60 (526.03), 2330–4400 |
median (Q1-Q3), min.-max. | 3310 (2800–3620), 970–4400 | 3190 (2800–3600), 2330–4400 |
APGAR rating, | ||
mean (SD), min.-max. | 8.78 (1.69), 3–10 | 8.54 (1.88), 1–10 |
median (Q1-Q3), min.-max. | 9 (8–10), 3–10 | 9 (9–9), 1–10 |
F508del mutation, n (%) | ||
overall | 24 (88.89) | 46 (88.46) |
in both alleles | 8 (29.63) | 26 (50.00) |
Meconium ileus, n (%) | 9 (33.33) | 9 (17.31) |
Concentration of chlorides (mmol/l), | ||
mean (SD), min.-max. | 98.93 (25.14), 10–123 | 100.83 (20.36), 60–152 |
median (Q1-Q3), min.-max. | 106 (89.117), 10–123 | 100 (90–110), 60–152 |